Models

Dataset Information

0

Cappuccio2006 - Cancer immunotherapy by interleukin-21

ABSTRACT: This model describes the effects of Il-21 on tumor eradication via natural killer cell-mediated and CD8+ T-cell-mediated lysis of tumor cells. The model demonstrates changes in growth dynamics in nonimmunogenic B16 melanoma and the immunogenic MethA and MCA205 fibrosarcomas, showing a strong dependence of the NK-cell/CD8+ T-cell balance on tumor immunogenicity.

SUBMITTER: Johannes Meyer  

PROVIDER: BIOMD0000000761 | BioModels | 2024-09-02

REPOSITORIES: BioModels

Json Xml

Dataset's files

Source:
Action DRS
BIOMD0000000761?filename=Cappuccio2006%20v2.0-biopax2.owl Owl
BIOMD0000000761?filename=Cappuccio2006%20v2.0-biopax3.owl Owl
BIOMD0000000761?filename=Cappuccio2006%20v2.0-matlab.m Other
BIOMD0000000761?filename=Cappuccio2006%20v2.0-octave.m Other
BIOMD0000000761?filename=Cappuccio2006%20v2.0.ode Other
Items per page:
1 - 5 of 12
altmetric image

Publications

Cancer immunotherapy by interleukin-21: potential treatment strategies evaluated in a mathematical model.

Cappuccio Antonio A   Elishmereni Moran M   Agur Zvia Z  

Cancer research 20060701 14

The newly characterized interleukin (IL)-21 plays a central role in the transition from innate immunity to adaptive immunity and shows substantial tumor regression in mice. IL-21 is now developed as a cancer immunotherapeutic drug, but conditions for efficacious therapy, and the conflicting immunostimulatory and immunoinhibitory influence of the cytokine, are yet to be defined. We studied the effects of IL-21 on tumor eradication in a mathematical model focusing on natural killer (NK) cell-media  ...[more]